Comparison of Procedural Sedation in TEE

PHASE1RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

February 25, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions
Anesthesia
Interventions
DRUG

Remimazolam

Remimazolam is an ultra-short acting benzodiazepine medication. Benzodiazepines are a class of drug that directly interact with gamma-aminobutyric acid (GABA) and modifiable chloride channels through polysynaptic pathway inhibition. The anxiolytic properties of benzodiazepines make them useful as sedatives.

DRUG

Propofol

Standard of care usage of the intravenous anesthetic agent propofol to achieve adequate sedation conditions for the procedure.

Trial Locations (1)

35233

RECRUITING

University of Alabama at Birmingham Hospital, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER